Skip to main content
Top
Published in: AIDS and Behavior 10/2018

01-10-2018 | Original Paper

Trajectories of Depressive Symptoms Among a Population of HIV-Infected Men and Women in Routine HIV Care in the United States

Authors: Angela M. Bengtson, Brian W. Pence, Kimberly A. Powers, Mark A. Weaver, Matthew J. Mimiaga, Bradley N. Gaynes, Conall O’Cleirigh, Katerina Christopoulos, W. Christopher Mathews, Heidi Crane, Michael Mugavero

Published in: AIDS and Behavior | Issue 10/2018

Login to get access

Abstract

Depressive symptoms vary in severity and chronicity. We used group-based trajectory models to describe trajectories of depressive symptoms (measured using the Patient Health Questionnaire-9) and predictors of trajectory group membership among 1493 HIV-infected men (84%) and 292 HIV-infected women (16%). At baseline, 29% of women and 26% of men had depressive symptoms. Over a median of 30 months of follow-up, we identified four depressive symptom trajectories for women (labeled “low” [experienced by 56% of women], “mild/moderate” [24%], “improving” [14%], and “severe” [6%]) and five for men (“low” [61%], “mild/moderate” [14%], “rebounding” [5%], “improving” [13%], and “severe” [7%]). Baseline antidepressant prescription, panic symptoms, and prior mental health diagnoses were associated with more severe or dynamic depressive symptom trajectories. Nearly a quarter of participants experienced some depressive symptoms, highlighting the need for improved depression management. Addressing more severe or dynamic depressive symptom trajectories may require interventions that additionally address mental health comorbidities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.CrossRef Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.CrossRef
2.
go back to reference Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725–30.CrossRef Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725–30.CrossRef
3.
go back to reference Bengtson AM, Pence BW, O’Donnell J, Thielman N, Heine A, Zinski A, et al. Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care. 2015;27(1):47–53.CrossRef Bengtson AM, Pence BW, O’Donnell J, Thielman N, Heine A, Zinski A, et al. Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care. 2015;27(1):47–53.CrossRef
4.
go back to reference Zimpel RR, Fleck MP. Depression as a major impact on the quality of life of HIV-positive Brazilians. Psychol Health Med. 2014;19(1):47–58.CrossRef Zimpel RR, Fleck MP. Depression as a major impact on the quality of life of HIV-positive Brazilians. Psychol Health Med. 2014;19(1):47–58.CrossRef
5.
go back to reference Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.CrossRef Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.CrossRef
6.
go back to reference Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–90.CrossRef Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–90.CrossRef
7.
go back to reference Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466–74.CrossRef Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466–74.CrossRef
8.
go back to reference Ironson G, O’Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67(6):1013–21.CrossRef Ironson G, O’Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67(6):1013–21.CrossRef
9.
go back to reference Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61(3):397–406.CrossRef Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61(3):397–406.CrossRef
10.
go back to reference Murphy K, Hoover DR, Shi Q, Cohen M, Gandhi M, Golub ET, et al. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States. Aids. 2013;27(15):2413–23.CrossRef Murphy K, Hoover DR, Shi Q, Cohen M, Gandhi M, Golub ET, et al. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States. Aids. 2013;27(15):2413–23.CrossRef
11.
go back to reference French AL, Gawel SH, Hershow R, Benning L, Hessol NA, Levine AM, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51(4):399–406.CrossRef French AL, Gawel SH, Hershow R, Benning L, Hessol NA, Levine AM, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51(4):399–406.CrossRef
12.
go back to reference Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garre M, et al. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther. 2007;12(7):1067–74.PubMed Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garre M, et al. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther. 2007;12(7):1067–74.PubMed
13.
go back to reference Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi WW, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44(4):470–7.CrossRef Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi WW, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44(4):470–7.CrossRef
14.
go back to reference Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, et al. Effects of antiretroviral therapy and depressive symptoms on all-cause mortality among HIV-infected women. Am J Epidemiol. 2017;185(10):869–78.CrossRef Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, et al. Effects of antiretroviral therapy and depressive symptoms on all-cause mortality among HIV-infected women. Am J Epidemiol. 2017;185(10):869–78.CrossRef
15.
go back to reference O’Cleirigh C, Newcomb ME, Mayer KH, Skeer M, Traeger L, Safren SA. Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a “prevention for positives” study. AIDS Behav. 2013;17(5):1764–9.CrossRef O’Cleirigh C, Newcomb ME, Mayer KH, Skeer M, Traeger L, Safren SA. Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a “prevention for positives” study. AIDS Behav. 2013;17(5):1764–9.CrossRef
16.
go back to reference Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450–60.CrossRef Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450–60.CrossRef
17.
go back to reference O’Cleirigh C, Magidson JF, Skeer MR, Mayer KH, Safren SA. Prevalence of psychiatric and substance abuse symptomatology among HIV-infected gay and bisexual men in HIV primary Care. Psychosomatics. 2015;56(5):470–8.CrossRef O’Cleirigh C, Magidson JF, Skeer MR, Mayer KH, Safren SA. Prevalence of psychiatric and substance abuse symptomatology among HIV-infected gay and bisexual men in HIV primary Care. Psychosomatics. 2015;56(5):470–8.CrossRef
18.
go back to reference Pence BW, Gaynes BN, Adams JL, Thielman NM, Heine AD, Mugavero MJ, et al. The effect of antidepressant treatment on HIV and depression outcomes: the SLAM DUNC randomized trial. AIDS. 2015;29(15):1975–86.CrossRef Pence BW, Gaynes BN, Adams JL, Thielman NM, Heine AD, Mugavero MJ, et al. The effect of antidepressant treatment on HIV and depression outcomes: the SLAM DUNC randomized trial. AIDS. 2015;29(15):1975–86.CrossRef
19.
go back to reference Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.CrossRef Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.CrossRef
20.
go back to reference Spies G, Asmal L, Seedat S. Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review. J Affect Disord. 2013;150(2):171–80.CrossRef Spies G, Asmal L, Seedat S. Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review. J Affect Disord. 2013;150(2):171–80.CrossRef
21.
go back to reference Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, et al. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013;103(2):308–15.CrossRef Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, et al. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013;103(2):308–15.CrossRef
22.
go back to reference Watson LC, Amick HR, Gaynes BN, Brownley KA, Thaker S, Viswanathan M, et al. Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health. 2013;4(4):294–306.CrossRef Watson LC, Amick HR, Gaynes BN, Brownley KA, Thaker S, Viswanathan M, et al. Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health. 2013;4(4):294–306.CrossRef
23.
go back to reference Kim MH, Mazenga AC, Devandra A, Ahmed S, Kazembe PN, Yu X, et al. Prevalence of depression and validation of the Beck Depression Inventory-II and the Children’s Depression Inventory-Short amongst HIV-positive adolescents in Malawi. J Int AIDS Soc. 2014;17:18965.CrossRef Kim MH, Mazenga AC, Devandra A, Ahmed S, Kazembe PN, Yu X, et al. Prevalence of depression and validation of the Beck Depression Inventory-II and the Children’s Depression Inventory-Short amongst HIV-positive adolescents in Malawi. J Int AIDS Soc. 2014;17:18965.CrossRef
24.
go back to reference Nyirenda M, Chatterji S, Rochat T, Mutevedzi P, Newell ML. Prevalence and correlates of depression among HIV-infected and -affected older people in rural South Africa. J Affect Disord. 2013;151(1):31–8.CrossRef Nyirenda M, Chatterji S, Rochat T, Mutevedzi P, Newell ML. Prevalence and correlates of depression among HIV-infected and -affected older people in rural South Africa. J Affect Disord. 2013;151(1):31–8.CrossRef
25.
go back to reference Rochat TJ, Tomlinson M, Barnighausen T, Newell ML, Stein A. The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord. 2011;135(1–3):362–73.CrossRef Rochat TJ, Tomlinson M, Barnighausen T, Newell ML, Stein A. The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord. 2011;135(1–3):362–73.CrossRef
26.
go back to reference Su X, Lau JT, Mak WW, Choi KC, Chen L, Song J, et al. Prevalence and associated factors of depression among people living with HIV in two cities in China. J Affect Disord. 2013;149(1–3):108–15.CrossRef Su X, Lau JT, Mak WW, Choi KC, Chen L, Song J, et al. Prevalence and associated factors of depression among people living with HIV in two cities in China. J Affect Disord. 2013;149(1–3):108–15.CrossRef
27.
go back to reference Tesfaw G, Ayano G, Awoke T, Assefa D, Birhanu Z, Miheretie G, et al. Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia. BMC Psychiatry. 2016;16(1):368.CrossRef Tesfaw G, Ayano G, Awoke T, Assefa D, Birhanu Z, Miheretie G, et al. Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia. BMC Psychiatry. 2016;16(1):368.CrossRef
28.
go back to reference Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, et al. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord. 2012;141(2–3):361–6.CrossRef Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, et al. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord. 2012;141(2–3):361–6.CrossRef
29.
go back to reference Choi SK, Boyle E, Cairney J, Collins EJ, Gardner S, Bacon J, et al. Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV Treatment Network Cohort Study. PLoS ONE. 2016;11(11):e0165816.CrossRef Choi SK, Boyle E, Cairney J, Collins EJ, Gardner S, Bacon J, et al. Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV Treatment Network Cohort Study. PLoS ONE. 2016;11(11):e0165816.CrossRef
30.
go back to reference Johnson JG, Rabkin JG, Lipsitz JD, Williams JB, Remien RH. Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study. Compr Psychiatry. 1999;40(1):31–4.CrossRef Johnson JG, Rabkin JG, Lipsitz JD, Williams JB, Remien RH. Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study. Compr Psychiatry. 1999;40(1):31–4.CrossRef
31.
go back to reference Taniguchi T, Shacham E, Onen NF, Grubb JR, Overton ET. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care. 2014;26(8):1004–12.CrossRef Taniguchi T, Shacham E, Onen NF, Grubb JR, Overton ET. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care. 2014;26(8):1004–12.CrossRef
32.
go back to reference Kitahata MM, Rodriguez B, Haubrich R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol. 2008;37(5):948–55.CrossRef Kitahata MM, Rodriguez B, Haubrich R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol. 2008;37(5):948–55.CrossRef
33.
go back to reference Crane HM, Lober W, Webster E, Harrington RD, Crane PK, Davis TE, et al. Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients. Curr HIV Res. 2007;5(1):109–18.CrossRef Crane HM, Lober W, Webster E, Harrington RD, Crane PK, Davis TE, et al. Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients. Curr HIV Res. 2007;5(1):109–18.CrossRef
34.
go back to reference Fredericksen R, Crane PK, Tufano J, Ralston J, Schmidt S, Brown T, et al. Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults. J AIDS HIV Res. 2012;4(2):47–55.CrossRef Fredericksen R, Crane PK, Tufano J, Ralston J, Schmidt S, Brown T, et al. Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults. J AIDS HIV Res. 2012;4(2):47–55.CrossRef
35.
go back to reference Nagin DS. Group-based modeling of development. Cambridge: Harvard University Press; 2005.CrossRef Nagin DS. Group-based modeling of development. Cambridge: Harvard University Press; 2005.CrossRef
36.
go back to reference Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRef Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRef
37.
go back to reference Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.CrossRef Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.CrossRef
38.
go back to reference Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.CrossRef Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.CrossRef
39.
go back to reference Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT, The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. Geneva, Switzerland: World Health Organization, Dependence DoMHaS; 2001. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT, The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. Geneva, Switzerland: World Health Organization, Dependence DoMHaS; 2001.
40.
go back to reference WHO Assist Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRef WHO Assist Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRef
41.
go back to reference Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–47.CrossRef Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–47.CrossRef
42.
go back to reference Bengtson AM, Pence BW, Crane HM, Christopoulos K, Fredericksen RJ, Gaynes BN, et al. Disparities in Depressive symptoms and antidepressant treatment by gender and race/ethnicity among people living with HIV in the United States. PLoS ONE. 2016;11(8):e0160738.CrossRef Bengtson AM, Pence BW, Crane HM, Christopoulos K, Fredericksen RJ, Gaynes BN, et al. Disparities in Depressive symptoms and antidepressant treatment by gender and race/ethnicity among people living with HIV in the United States. PLoS ONE. 2016;11(8):e0160738.CrossRef
43.
go back to reference Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res. 2001;29(3):374–93.CrossRef Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res. 2001;29(3):374–93.CrossRef
44.
go back to reference Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.CrossRef Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.CrossRef
45.
go back to reference Madhoo M, Levine SZ. Initial severity effects on residual symptoms in response and remission: a STAR*D Study during and after failed citalopram treatment. J Clin Psychopharmacol. 2015;35(4):450–3.PubMed Madhoo M, Levine SZ. Initial severity effects on residual symptoms in response and remission: a STAR*D Study during and after failed citalopram treatment. J Clin Psychopharmacol. 2015;35(4):450–3.PubMed
46.
go back to reference Barroso J, Bengtson AM, Gaynes BN, McGuinness T, Quinlivan EB, Ogle M, et al. Improvements in depression and changes in fatigue: results from the SLAM DUNC depression treatment trial. AIDS Behav. 2016;20(2):235–42.CrossRef Barroso J, Bengtson AM, Gaynes BN, McGuinness T, Quinlivan EB, Ogle M, et al. Improvements in depression and changes in fatigue: results from the SLAM DUNC depression treatment trial. AIDS Behav. 2016;20(2):235–42.CrossRef
47.
go back to reference Illangasekare SL, Burke JG, McDonnell KA, Gielen AC. The impact of intimate partner violence, substance use, and HIV on depressive symptoms among abused low-income urban women. J Interpers Violence. 2013;28(14):2831–48.CrossRef Illangasekare SL, Burke JG, McDonnell KA, Gielen AC. The impact of intimate partner violence, substance use, and HIV on depressive symptoms among abused low-income urban women. J Interpers Violence. 2013;28(14):2831–48.CrossRef
48.
go back to reference Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med. 2015;16(10):1870–81.CrossRef Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med. 2015;16(10):1870–81.CrossRef
49.
go back to reference Gaynes BN, O’Donnell J, Nelson E, Heine A, Zinski A, Edwards M, et al. Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. Gen Hosp Psychiatry. 2015;37(4):277–82.CrossRef Gaynes BN, O’Donnell J, Nelson E, Heine A, Zinski A, Edwards M, et al. Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. Gen Hosp Psychiatry. 2015;37(4):277–82.CrossRef
50.
go back to reference Simon NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry. 2009;70(Suppl 2):10–4.CrossRef Simon NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry. 2009;70(Suppl 2):10–4.CrossRef
51.
go back to reference Pence BW, O’Donnell JK, Gaynes BN. The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep. 2012;14(4):328–35.CrossRef Pence BW, O’Donnell JK, Gaynes BN. The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep. 2012;14(4):328–35.CrossRef
52.
go back to reference Bengtson AM, Pence PW, Crane HM, Christopoulos K, Fredericksen R, Gaynes BN, et al. Disparities in depression diagnosis and treatment by gender and race/ethnicity among HIV-infected adults in the United States. PLoS One. 2016;11(8):e160738.CrossRef Bengtson AM, Pence PW, Crane HM, Christopoulos K, Fredericksen R, Gaynes BN, et al. Disparities in depression diagnosis and treatment by gender and race/ethnicity among HIV-infected adults in the United States. PLoS One. 2016;11(8):e160738.CrossRef
53.
go back to reference Traeger L, O’Cleirigh C, Skeer MR, Mayer KH, Safren SA. Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med. 2012;35(5):548–56.CrossRef Traeger L, O’Cleirigh C, Skeer MR, Mayer KH, Safren SA. Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med. 2012;35(5):548–56.CrossRef
Metadata
Title
Trajectories of Depressive Symptoms Among a Population of HIV-Infected Men and Women in Routine HIV Care in the United States
Authors
Angela M. Bengtson
Brian W. Pence
Kimberly A. Powers
Mark A. Weaver
Matthew J. Mimiaga
Bradley N. Gaynes
Conall O’Cleirigh
Katerina Christopoulos
W. Christopher Mathews
Heidi Crane
Michael Mugavero
Publication date
01-10-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 10/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2109-2

Other articles of this Issue 10/2018

AIDS and Behavior 10/2018 Go to the issue